Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Mark Vranicar

Pediatric Cardiology Augusta, GA Medical Doctor

NPI 1841215647 CMS profile 1013635

1446 Harper St Fl 6, Augusta, GA 30912

Open in the dashboard

General payments

$2,904

44 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$30,031 paid to institutions, not to them · program years 2019–2022

Through program year 2025, Mark Vranicar of Augusta, GA is reported in the CMS Open Payments database as having received $2,904 across 44 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $30,031 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 80th percentile of Pediatric Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $215 7
2024 General $1,348 15
2023 General $174 6
2022 General $1,075 15
2021 General $92 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mark Vranicar
  • Pediatric Cardiology median
  • Middle half of Pediatric Cardiology
  • National median

In program year 2025, general payments to Mark Vranicar were reported at $215. Among 1,168 Pediatric Cardiology profiles paid that year, the median was $146 and the middle half received between $47 and $670.

Show as a table
Year Mark Vranicar Pediatric Cardiology median Middle half National median
2019 $0 $124 $35–$516 $163
2020 $0 $70 $23–$326 $114
2021 $92 $112 $27–$445 $132
2022 $1,075 $129 $36–$680 $149
2023 $174 $149 $38–$826 $160
2024 $1,348 $131 $37–$652 $164
2025 $215 $146 $47–$670 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Siemens Medical Solutions USA, Inc. $1,266 11 payments
  2. Abbott Laboratories $1,217 17 payments
  3. B. Braun Interventional Systems Inc. $127 3 payments
  4. W. L. Gore & Associates, Inc. $95 5 payments
  5. Philips Electronics North America Corporation $83 4 payments
  6. Vital Connect, Inc $53 2 payments
  7. Boston Scientific Corporation $33 1 payment
  8. CutisPharma, Inc. $30 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Travel and Lodging $1,611 10 payments
  2. Food and Beverage $1,292 34 payments
Products named General payments · program years 2021–2025
  1. ARTIS icono biplane $1,197 9 payments
  2. AMPLATZER Structural Heart $680 6 payments
  3. AMPLATZER Structural Heart $282 4 payments
  4. AMPLATZER PICCOLO $96 4 payments
  5. AMPLATZER Occluders $92 1 payment
  6. CP STENT $80 2 payments
  7. GORE CARDIOFORM Septal Occluder $72 4 payments
  8. Artis icono floor $54 1 payment
  9. VITALPATCH RTM $53 2 payments
  10. NA $46 1 payment
  11. Other $263 11 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

44 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Cardiology in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record